In a prior study, Riahi-Chebbi et al. (2019) reported that kaempferol treatment in colon cancer cells decreased the expression of RB phosphorylation and cyclin-dependent kinase (cdc2), and enhanced p53 and p-53 phosphorylation [19]. Here, TP53 is linked to colonic neoplasm.